Literature DB >> 21949152

The use of systemic and topical fluoroquinolones.

John S Bradley, Mary Anne Jackson.   

Abstract

Appropriate prescribing practices for fluoroquinolones are essential as evolving resistance patterns are considered, additional treatment indications are identified, and the toxicity profile of fluoroquinolones in children becomes better defined. Earlier recommendations for systemic therapy remain; expanded uses of fluoroquinolones for the treatment of certain infections are outlined in this report. Although fluoroquinolones are reasonably safe in children, clinicians should be aware of the specific adverse reactions. Use of fluoroquinolones in children should continue to be limited to treatment of infections for which no safe and effective alternative exists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21949152     DOI: 10.1542/peds.2011-1496

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  39 in total

1.  Occurrence of Antimicrobial-Resistant Escherichia coli and Salmonella enterica in the Beef Cattle Production and Processing Continuum.

Authors:  John W Schmidt; Getahun E Agga; Joseph M Bosilevac; Dayna M Brichta-Harhay; Steven D Shackelford; Rong Wang; Tommy L Wheeler; Terrance M Arthur
Journal:  Appl Environ Microbiol       Date:  2014-11-14       Impact factor: 4.792

Review 2.  Lessons Learned in Antibiotic Stewardship: Fluoroquinolone Use in Pediatrics.

Authors:  Adam L Hersh; Jeffrey S Gerber; Lauri A Hicks; Andrew T Pavia
Journal:  J Pediatric Infect Dis Soc       Date:  2014-05-23       Impact factor: 3.164

3.  In children with chronic suppurative otitis media, should one prescribe topical or systemic antibiotics?

Authors:  N Sandhu; D Thomson; A Stang
Journal:  Paediatr Child Health       Date:  2012-08       Impact factor: 2.253

4.  Observational cohort study of pregnancy outcome after first-trimester exposure to fluoroquinolones.

Authors:  Stephanie Padberg; Evelin Wacker; Reinhard Meister; Mary Panse; Corinna Weber-Schoendorfer; Marc Oppermann; Christof Schaefer
Journal:  Antimicrob Agents Chemother       Date:  2014-05-19       Impact factor: 5.191

5.  Herb drug interaction: effect of Manix® on pharmacokinetic parameters of pefloxacin in rat model.

Authors:  Sunday Odunke Nduka; Eleje Okonta; Chika Christiana Abba; Peter Chibueze Ihekwereme; Uchenna Ekwedigwe; Matthew Okonta
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

Review 6.  An update on drug-induced arthritis.

Authors:  Marwan H Adwan
Journal:  Rheumatol Int       Date:  2016-03-21       Impact factor: 2.631

Review 7.  Traveler's Diarrhea.

Authors:  Stanley L Giddings; A Michal Stevens; Daniel T Leung
Journal:  Med Clin North Am       Date:  2016-03       Impact factor: 5.456

8.  Levofloxacin Use in the Neonate: A Case Series.

Authors:  Brandi D Newby; Kathryn E Timberlake; Lyndsay M Lepp; Tamara Mihic; Deonne A Dersch-Mills
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Jul-Aug

9.  Pediatric anthrax clinical management.

Authors:  John S Bradley; Georgina Peacock; Steven E Krug; William A Bower; Amanda C Cohn; Dana Meaney-Delman; Andrew T Pavia
Journal:  Pediatrics       Date:  2014-05       Impact factor: 7.124

10.  [Diagnostics and therapy of urinary tract infections].

Authors:  R Beetz; F Wagenlehner
Journal:  Urologe A       Date:  2013-01       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.